Jeffrey Mitchell
Director of Finance/CFO at LEXAGENE HOLDINGS INC.
Net worth: 28 076 $ as of 2023-01-30
Profile
Jeffrey Mitchell is currently the Chief Financial Officer, Secretary & Treasurer at Lexagene Holdings, Inc. since 2018.
Prior to this, he worked as a Finance Director & Controller at Palomar Medical Technologies LLC.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LEXAGENE HOLDINGS INC.
0.11% | 2022-12-18 | 152,585 ( 0.11% ) | 28 076 $ | 2023-01-30 |
Jeffrey Mitchell active positions
Companies | Position | Start |
---|---|---|
LEXAGENE HOLDINGS INC. | Director of Finance/CFO | 2018-02-28 |
Former positions of Jeffrey Mitchell
Companies | Position | End |
---|---|---|
PALOMAR MEDICAL TECHNOLOGIES INC | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LEXAGENE HOLDINGS INC. | Health Technology |
Private companies | 1 |
---|---|
Palomar Medical Technologies LLC
Palomar Medical Technologies LLC Electronic ComponentsElectronic Technology Palomar Medical Technologies LLC engages in the research, development, manufacturing and distribution of light based systems for cosmetic treatments. The company is involved in developing a differentiated product mix of light-based systems for various treatments through its research and development as well as with its partnerships throughout the world. It is continually developing and testing new indications to further the advancement in light-based treatments. The company operates through two segments: Professional Product and Consumer Product. The Professional Product segment includes all of its light-based products and services for the professional market. The Consumer Product segment includes PaloVia. It offers products based on technologies that include hair removal, body sculpting, including laser-assisted liposuction, removal of vascular lesions such as rosacea, spider veins, port wine stains and hemangiomas, wrinkle reduction, removal of leg veins, removal of benign pigmented lesions such as age and sun spots, freckles and melasma, tattoo removal, acne treatment, skin resurfacing, treatment of red pigmentation in hypertrophic and keloid scars, treatment of verrucae, skin tags, seborrheic keratosis, skin tightening through soft tissue coagulation, removal of scars, including acne scars, stretch marks and warts and soft tissue coagulation. Palomar Medical Technologies was founded in 1987 and is headquartered in Burlington, MA. | Electronic Technology |
- Stock Market
- Insiders
- Jeffrey Mitchell